glp 1 cardiovascular risk Are you on an GLP-1 agonist like Wegovy? Zepbound? The craze is real. The data is strong. The heart is protected The Multidisciplinary Approach to GLP-1

Morpheus8 pairs well with Botox (done 2 weeks prior), dermal fillers (done 2 weeks after), PRF applied immediately post-treatment, and HydraFacial (done 4+ weeks post-Morpheus8 once skin has healed)

Diabetes Therapy, 2021 A meta-analysis of cardiovascular outcomes trials showing that GLP-1 receptor agonists improve heart health in patients with type 2 diabetes, with dosing levels influencing tolerability and side effect profiles

Its important to discuss any concerns or health issues with a clinician

Trimetazidine improved adriamycin-induced cardiomyopathy by downregulating TNF-, BAX, and VEGF immunoexpression via an antioxidant mechanism

3.5 Respiratory protection In December 2024, tirzepatide received FDA approval for the treatment of moderate-to-severe obstructive sleep apnea (OSA) in obese adults (Yu et al., 2023)